Vioxx Research - Osteoarthritis, Side-effects, Trials, Stroke, Heart Attack

Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.


Vioxx Research Today

Home

View Latest Issue

Information About Vioxx

Books on Vioxx

Advertising in Research Today

View Other Research Today Publications



Volume 5 (2008), Issue 6 (June)

  1. Validating the effects of drug treatment on blood pressure in the General Practice Research Database.
    Pharmacoepidemiol Drug Saf, 17(6): 535-45. [Abstract] [Full-text]
  2. Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis.
    Pharmacoepidemiol Drug Saf, 17(6): 601-8. [Abstract] [Full-text]
  3. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.
    Arch Intern Med, 168(11): 1219-24. [Abstract] [Full-text]
  4. Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G.
    Mol Carcinog, 47(7): 519-25. [Abstract] [Full-text]
  5. A randomized trial of the peri-operative use of COX-2 inhibitors in Lichtenstein herniorrhaphy.
    Hernia. [Abstract] [Full-text]
  6. COX2-selective and non-selective NSAIDs induce oxidative stress by upregulating vascular NADPH oxidases.
    J Pharmacol Exp Ther. [Abstract] [Full-text]
  7. COX inhibitors downregulate PDE4D expression in a clinical model of inflammatory pain.
    Clin Pharmacol Ther, 84(1): 39-42. [Abstract] [Full-text]
  8. Was the thrombotic risk of rofecoxib predictible from the French Pharmacovigilance Database before 30 September 2004?
    Eur J Clin Pharmacol, 64(8): 829-34. [Abstract] [Full-text]
  9. Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves.
    J Pharmacol Exp Ther, 326(1): 105-16. [Abstract] [Full-text]
  10. Prothrombotic effect of Rofecoxib in a murine venous thrombosis model.
    Thromb Res. [Abstract] [Full-text]
  11. Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke.
    Stroke, 39(7): 2037-45. [Abstract] [Full-text]
  12. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Biochem Pharmacol, 76(2): 179-87. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Vioxx Research Today. All Rights Reserved.



Vioxx Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)



Vioxx Books

Columbia Presbyterian Osteoarthritis Handbook

Columbia Presbyterian Osteoarthritis Handbook